{"companyId":277656,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","ja"],"companyName":"Barinthus Biotherapeutics plc","headOfficeLocation":"ハーウェル、イギリス","presidentName":"ビル・エンライト","companySummary":null,"stockCode":"BRNS","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["barinthusbio.com"],"businessContents":["臨床段階のバイオ医薬品免疫療法の開発","感染症、癌、自身免疫疾患の治療"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://www.barinthusbio.com/about/","scoreAbout":500,"scoreBusiness":300,"scoreGroup":0,"scoreCustomer":0}]}